Atea Pharmaceuticals (AVIR) Q1 2025 Earnings

Mar 6Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.75
-0.6
-0.44
-0.29

Details

Expected EPS
-0.288729
Actual EPS
-0.4
Surprise EPS
-0.11
Surprise Percent
-38.54%

Description

⁨Atea Pharmaceuticals⁩ (⁦AVIR⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts